TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›NIMU›Financials
Annual statements · SEC XBRL · FY2016 – FY2025

NON INVASIVE MONITORING SYSTEMS INC /FL/ (NIMU) financials

Income statement

NON INVASIVE MONITORING SYSTEMS INC /FL/ (NIMU) income statement, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$23.0K$6.00K————————
Revenue growth—-73.9%————————
Operating income-$572K-$295K-$178K-$446K-$165K-$158K-$159K-$169K-$59.0K-$160K
Operating margin-2487.0%-4916.7%————————
Net income-$741K-$488K-$445K-$1.61M-$163K-$158K-$173K-$199K-$113K-$222K
Net margin-3221.7%-8133.3%————————
EPS (diluted)-$0.01-$0.01-$0.01-$0.01$0.00$0.00$0.00$0.00$0.00$0.00

Cash flow

NON INVASIVE MONITORING SYSTEMS INC /FL/ (NIMU) cash flow, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow-$278K-$176K-$221K-$437K-$150K-$148K-$190K-$158K-$182K-$117K

Balance sheet

NON INVASIVE MONITORING SYSTEMS INC /FL/ (NIMU) balance sheet, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$87.0K$11.0K$90.0K$353K$203K$55.0K$15.0K$7.00K$25.0K$3.00K
Total assets$242K$21.0K$110K$361K$206K$59.0K$21.0K$23.0K$34.0K$7.00K
Total liabilities$2.99M$3.25M$3.79M$280K$288K$299K$434K$635K$759K$954K
Long-term debt$1.73M$1.93M————————
Shareholders' equity-$2.75M-$3.23M-$3.68M$81.0K-$82.0K-$240K-$413K-$612K-$725K-$947K
Retained earnings-$25.5M-$26.0M-$26.5M-$28.0M-$28.2M-$28.4M-$28.5M-$28.7M-$28.8M-$29.1M
Shares (wtd avg diluted)79.0M79.0M79.0M155M155M155M155M155M155M155M

Every figure is extracted from NON INVASIVE MONITORING SYSTEMS INC /FL/’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

Does NIMU pay a dividend?
NON INVASIVE MONITORING SYSTEMS INC /FL/ reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full NIMU analysis — verdict, score & filings →Is NIMU a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.